A Phase 2 Study of OSI-906 in Patients With Asymptomatic or Mildly Symptomatic (Non-Opioid Requiring) Metastatic Castrate Resistant Prostate Cancer (CRPC)
Phase of Trial: Phase II
Latest Information Update: 20 Mar 2015
At a glance
- Drugs Linsitinib (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 28 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2012 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.